A detailed history of Maple Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Maple Capital Management, Inc. holds 46,716 shares of LLY stock, worth $37.2 Million. This represents 3.16% of its overall portfolio holdings.

Number of Shares
46,716
Previous 46,593 0.26%
Holding current value
$37.2 Million
Previous $42.2 Million 1.89%
% of portfolio
3.16%
Previous 3.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$772.14 - $960.02 $94,973 - $118,082
123 Added 0.26%
46,716 $41.4 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $87,709 - $109,993
121 Added 0.26%
46,593 $42.2 Million
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $562,590 - $752,666
-950 Reduced 2.0%
46,472 $36.2 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $1.53 Million - $1.8 Million
-2,911 Reduced 5.78%
47,422 $27.6 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $1.58 Million - $2.17 Million
-3,628 Reduced 6.72%
50,333 $27 Million
Q2 2023

Jul 14, 2023

SELL
$350.74 - $468.98 $101,714 - $136,004
-290 Reduced 0.53%
53,961 $25.3 Million
Q1 2023

May 02, 2023

SELL
$310.63 - $364.82 $261,239 - $306,813
-841 Reduced 1.53%
54,251 $18.6 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $530,235 - $617,830
-1,649 Reduced 2.91%
55,092 $20.2 Million
Q3 2022

Nov 15, 2022

SELL
$296.48 - $337.87 $5.95 Million - $6.78 Million
-20,059 Reduced 26.12%
56,741 $20.2 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $309,947 - $363,924
1,112 Added 1.47%
76,800 $24.9 Million
Q1 2022

May 17, 2022

SELL
$234.69 - $291.66 $38,489 - $47,832
-164 Reduced 0.22%
75,688 $21.7 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $304,446 - $377,820
-1,354 Reduced 1.75%
75,852 $21 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $337,718 - $415,610
-1,524 Reduced 1.94%
77,206 $17.8 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $231,104 - $298,931
-1,280 Reduced 1.6%
78,730 $20.8 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $23,990 - $31,057
-146 Reduced 0.18%
80,010 $14.9 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $56,880 - $75,266
-436 Reduced 0.54%
80,156 $13.5 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $112,296 - $129,891
768 Added 0.96%
80,592 $11.5 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $155,245 - $186,836
-1,138 Reduced 1.41%
79,824 $13.1 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $243,695 - $301,625
-2,047 Reduced 2.47%
80,962 $11.2 Million
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $72,919 - $90,317
682 Added 0.83%
83,009 $10.9 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $476,603 - $518,422
-4,463 Reduced 5.14%
82,327 $9.21 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $500,438 - $584,138
-4,517 Reduced 4.95%
86,790 $9.62 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $945,912 - $1.11 Million
-8,498 Reduced 8.51%
91,307 $11.8 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $49,773 - $55,760
470 Added 0.47%
99,805 $11.5 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $40,611 - $50,757
-473 Reduced 0.47%
99,335 $0
Q2 2018

Aug 08, 2018

BUY
$75.7 - $86.88 $28,009 - $32,145
370 Added 0.37%
99,808 $0
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $135,210 - $159,607
1,822 Added 1.87%
99,438 $0
Q4 2017

Feb 15, 2018

BUY
$81.94 - $87.89 $118,813 - $127,440
1,450 Added 1.51%
97,616 $8.25 Million
Q3 2017

Nov 03, 2017

BUY
$77.07 - $85.54 $7.41 Million - $8.23 Million
96,166
96,166 $8.23 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Maple Capital Management, Inc. Portfolio

Follow Maple Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.